The active form of vitamin D, calcitriol, induces a complex dual upregulation of endothelin and nitric oxide in cultured endothelial cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 12, 2014, Pages E1085-E1096

  Martínez Miguel, Patricia ^a   Valdivielso, Jose Manuel ^b   Medrano Andrés, Diana ^a   Román García, Pablo ^c,d   Cano Peñalver, Jose Luis ^e   Rodríguez Puyol, Manuel ^d,e   Rodríguez Puyol, Diego ^a,d   López Ongil, Susana ^a,d  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d Instituto Reina Sofía de Investigaciones Nefrológicas   (Spain)

^e UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,6,8,13 TETRAHYDRO 1,6,9,14 TETRAHYDROXY 3 (2 HYDROXYPROPYL) 7 METHOXY 8,13 DIOXOBENZO[A]NAPHTHACENE 2 CARBOXYLIC ACID; CALCITRIOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; MESSENGER RNA; NITRIC OXIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; VITAMIN D RECEPTOR; ASPARTIC PROTEINASE; CALCITRIOL RECEPTOR; ENDOTHELIN; ENDOTHELIN-CONVERTING ENZYME; METALLOPROTEINASE; NOS3 PROTEIN, HUMAN; VDR PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; GENETIC TRANSFECTION; HYPERTENSION; IN VIVO STUDY; LUNG PARENCHYMA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RAT; RECEPTOR UPREGULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BLOOD PRESSURE; CALCITRIOL; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELINS; HUMANS; MALE; METALLOENDOPEPTIDASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; RECEPTORS, CALCITRIOL; UP-REGULATION;

EID: 84918790949     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00156.2014     Document Type: Article

References (41)

1. Absi M, Ward DT. Increased endothelin-1 responsiveness in human coronary artery smooth muscle cells exposed to 1,25-dihydroxyvitamin D3. Am J Physiol Cell Physiol 304: C666–C672, 2013.
2. Brickman AS, Nyby MD, von Hungen K, Eggena P, Tuck ML. Calcitropic hormones, platelet calcium, and blood pressure in essential hypertension. Hypertension 16: 515–522, 1990.
3. Cardús A, Parisi E, Gallego C, Aldea M, Fernandez E, Valdivielso JM. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 69: 1377–1384, 2006.
4. Dong J, Wong SL, Lau CW, Liu J, Wang YX, Dan He Z, Fai Ng C, Yu Chen Z, Yao X, Xu A, Ni X, Wang H, Huang Y. Calcitriol restores renovascular function in estrogen-deficient rats through downregulation of cyclooxygenase-2 and the thromboxane-prostanoid receptor. Kidney Int 84: 54–63, 2013.
5. Dustan HP. Obesity and hypertension in blacks. Cardiovasc Drugs Ther 4: 385–402, 1990.
6. Flowers MA, Wang Y, Stewart RJ, Patel B, Marsden PA. Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells. Am J Physiol Heart Circ Physiol 269: H1988–H1997, 1995.
7. Geleijnse JM. Vitamin D and the prevention of hypertension and cardiovascular disease: a review of the current evidence. Am J Hypertens 24: 253–262, 2011.
8. González-Santiago L, López-Ongil S, Rodríguez-Puyol M, Rodríguez- Puyol D. Decreased nitric oxide synthesis in human endothelial cells cultured on type I collagen. Circ Res 90: 539–545, 2002.
9. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 92: 99–104, 1993.
10. Kristal-Boneh E, Froom P, Harari G, Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension 30: 1289–1294, 1997.
11. Kurtz TW, Portale AA, Morris RC. Evidence for a difference in vitamin D metabolism between spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 8: 1015–1020, 1986.
12. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229–238, 2002.
13. Lopez-Ongil S, Saura M, Zaragoza C, Gonzalez-Santiago L, Rodriguez- Puyol M, Lowestein CJ, Rodriguez-Puyol D. Hydrogen peroxide regulation of bovine endothelin-converting enzyme-1. Free Radic Biol Med 32: 406–413, 2002.
14. Lopez-Ongil S, Senchak V, Saura M, Zaragoza C, Ames M, Ballermann B, Rodriguez-Puyol M, Rodriguez-Puyol D, Lowenstein CJ. Superoxide regulation of endothelin-converting enzyme. J Biol Chem 275: 26423–26427, 2000.
15. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268: 17478–17488, 1993.
16. Martínez-Miguel P, Medrano-Andres D, Lopes-Martín V, Arribas- Gómez I, Rodríguez-Puyol M, Rodríguez-Puyol D, López-Ongil S. Regulation of endothelin-converting (ECE-1) by the calcimimetic R-568. Pharmacol Res 76: 106–118, 2013.
17. Martínez-Miguel P, Raoch V, Zaragoza C, Valdivielso JM, Rodríguez- Puyol M, Rodríguez-Puyol D, Lopez-Ongil S. Endothelin converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins. J Lipid Res 50: 364–375, 2009.
18. Meems LM, van der Harst P, van Gilst WH, de Boer RA. Vitamin D biology in heart failure: molecular mechanisms and systematic review. Curr Drug Targets 12: 29–41, 2011.
19. Merke J, Lucas PA, Szabo A, Cournot-Witmer G, Mall G, Bouillon R, Drüeke T, Mann J, Ritz E. Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat. Hypertension 13: 233–242, 1989.
20. Merke J, Milde P, Lewicka S, Hügel U, Klaus G, Mangelsdorf DJ, Haussler MR, Rauterberg EW, Ritz E. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25- dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 83: 1903–1915, 1989.
21. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorimetric assay for the measurement of nitrite in biological samples. Anal Biochem 214: 11–16, 1993.
22. Molinari C, Uberti F, Grossini E, Vacca G, Carda S, Invernizzi M, Cisari C. 1α,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 27: 661–668, 2011.
23. Panizo S, Cardús A, Encinas M, Parisi E, Valcheva P, López-Ongil S, Coll B, Fernandez E, Valdivielso JM. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 104: 1041–1048, 2009.
24. Qiao G, Kong J, Uskokovic M, Li YC. Analogs of 1-alpha,25-dihydroxyvitamin D as novel inhibitors of renin biosynthesis. J Steroid Biochem Mol Biol 96: 59–66, 2005.
25. Raoch V, Rodríguez-Pascual F, López-Martínez V, Medrano-Andrés D, Rodríguez-Puyol M, Lamas S, Rodríguez-Puyol D, López-Ongil S. Nitric oxide decreases the expression of endothelin-converting enzyme-1 through mRNA destabilization. Arterioscler Thromb Vasc Biol 31: 2577–2585, 2011.
26. Resnick LM, Laragh JH. Renin, calcium metabolism and the pathophysiologic basic of antihypertensive therapy. Am J Cardiol 56: 68H–74H, 1985.
27. Resnick LM, Müller FB, Laragh JH. Calcium-regulatin hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 105: 649–654, 1986.
28. Rossi GP, Seccia TM, Nussdorfer GG. Reciprocal regulation of endothelin- 1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int Rev Cytol 209: 241–272, 2001.
29. Savard S, Lavoie P, Villeneuve C, Agharazii M, Lebel M, Larivière R. eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass. Nephrol Dial Transplant 27: 2182–2190, 2012.
30. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond) 120: 357–375, 2011.
31. Sowers MR, Wallace RB, Hollis BW, Lemke JH. Relationship between 1,25-dihydroxyvitamin D and blood pressure in a geographically defined population. Am J Clin Nutr 48: 1053–1056, 1988.
32. Tamez H, Thadhani RI. Vitamin D and hypertension: an update and review. Curr Opin Nephrol Hypertens 21: 492–499, 2012
33. Uhlmann D, Witzigmann H, Senninger H, Hauss J, Spiegel HU. Protective role of an endothelin-converting enzyme inhibitor (FR901533) in hepatic ischemia/reperfusion injury. Microvasc Res 62: 43–54, 2001.
34. Valdenaire O, Rohrbacher E, Mattei MG. Organization of the gene encoding the human endothelin-converting enzyme-1 (ECE-1). J Biol Chem 270: 29794–29798, 1995.
35. Valdivielso JM, Coll B, Fernandez E. Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets 13: 29–38, 2009.
36. Weng S, Sprague JE, Oh J, Riek AE, Chin K, Garcia M, Bernal- Mizrachi C. Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One 8: e54625, 2013.
37. Wong MS, Delansorne R, Man RY, Vanhoutte PM. Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 295: H289–H296, 2008.
38. Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 299: H1226–H1234, 2010.
39. Wu W, Zhang X, Zanello LP. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21 (waf1) upregulation in human osteosarcoma. Cancer Lett 254: 75–86, 2007.
40. Young EW, McCarron DA, Morris CD. Calcium regulating in essential hypertension. Importance of gender. Am J Hypertens 3: 161S–166S, 1990.
41. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Willians MC, Stewart PM, Hewison M. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 13: 621–629, 2002.